Lexeo Therapeutics (LXEO) & Its Peers Head-To-Head Survey
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) is one of 287 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its rivals? We will compare Lexeo Therapeutics to related businesses based on the strength of its profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation. Analyst Recommendations This […]
More Stories
Sun Country Airlines (NASDAQ:SNCY) Hits New 12-Month High – Here’s What Happened
Sun Country Airlines Holdings, Inc. (NASDAQ:SNCY – Get Free Report)’s share price hit a new 52-week high on Friday ....
Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 9.8% Following Insider Selling
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) shares traded down 9.8% during mid-day trading on Friday following insider selling...
AppLovin (NASDAQ:APP) Stock Price Down 5.4% – Here’s Why
AppLovin Co. (NASDAQ:APP – Get Free Report)’s share price fell 5.4% on Friday . The company traded as low as...
Cohen & Steers Select Preferred and Income Fund, Inc. (PSF) To Go Ex-Dividend on January 14th
Cohen & Steers Select Preferred and Income Fund, Inc. (NYSE:PSF – Get Free Report) declared a monthly dividend on Wednesday,...
Montanaro UK Smaller Companies (MTU) To Go Ex-Dividend on January 16th
Montanaro UK Smaller Companies (LON:MTU – Get Free Report) declared a dividend on Friday, January 10th,Upcoming Dividends.Co.Uk reports. Investors of...
Cabot Co. (CBT) to Distribute Quarterly Dividend of $0.43 on March 14th
Cabot Co. (NYSE:CBT – Get Free Report) declared a quarterly dividend on Friday, January 10th,RTT News reports. Shareholders of record...